TY  - JOUR
AU  - Brugnera, Marco
AU  - Vicario De La Torre, Marta
AU  - González-Cela Casamayor, Miriam Ana
AU  - López Cano, José Javier
AU  - Bravo Osuna, Irene
AU  - Huete Toral, Fernando
AU  - González Rubio, María Luisa
AU  - Carracedo Rodríguez, Juan Gonzalo
AU  - Molina Martínez, Irene Teresa
AU  - Andrés Guerrero, Vanesa
AU  - Herrero Vanrell, María Del Rocío
PY  - 2024
DO  - 10.1007/s13346-024-01584-z
SN  - 2190-393X
UR  - https://hdl.handle.net/20.500.14352/104619
T2  - Drug Delivery and Translational Research
AB  - The first line of glaucoma treatment focuses on reducing intraocular pressure (IOP) through the prescription of topical prostaglandin analogues, such as latanoprost (LAT). Topical ophthalmic medicines have low bioavailability due to their rapid...
LA  - eng
PB  - Springer
KW  - Glaucoma
KW  - Hyaluronic acid
KW  - Latanoprost
KW  - Liposomes
KW  - Ocular drug delivery
KW  - Osmoprotectants
TI  - Enhancing the hypotensive effect of latanoprost by combining synthetic phosphatidylcholine liposomes with hyaluronic acid and osmoprotective agents
TY  - journal article
ER  -